If you notice hair loss while using any of these medicines, or if you are losing weight more rapidly than expected, contact your healthcare provider
has received grant support from AstraZeneca, Eli Lilly, Menarini/Berlin-Chemie, Merck, Sharp & Dohme, and NovoNordisk
there is no research proving the stack provides additional weight loss benefits compared to semaglutide monotherapy
Zepbound was approved for chronic weight management in adults in November 2023
With 10.1 crore people living with abnormal blood sugar levels, India is already regarded as the diabetes capital of the world
Metformin is a longstanding treatment for type 2 diabetes